Briefly, NK-cell-mediated tumor-cell cytotoxicity relies on the balance among ligands for activating receptors (e.g., NKG2D, DNAM-1, and NCRs) and those for inhibitory receptors (e.g., NKG2A and KIRs). This evidence concerns the gene KLRK1 and neoplasm.